Latest Insider Transactions at Clover Health Investments, Corp. (CLOV)
This section provides a real-time view of insider transactions for Clover Health Investments, Corp. (CLOV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CLOVER HEALTH INVESTMENTS, CORP. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CLOVER HEALTH INVESTMENTS, CORP. 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,020
-0.6%
|
$0
$0.95 P/Share
|
|
Feb 09
2024
|
Aric R Sharp CEO of Value Based Care |
SELL
Payment of exercise price or tax liability
|
Direct |
8,266
-0.46%
|
$8,266
$1.02 P/Share
|
|
Feb 08
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,367
-0.78%
|
$85,367
$1.0 P/Share
|
|
Jan 25
2024
|
Scott J. Leffler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
83,538
-1.69%
|
$0
$0.98 P/Share
|
|
Jan 18
2024
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
38,030
-1.93%
|
$0
$0.98 P/Share
|
|
Jan 07
2024
|
Vivek Garipalli Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,561,065
-100.0%
|
$0
$0.95 P/Share
|
|
Jan 07
2024
|
Vivek Garipalli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,561,065
+50.0%
|
-
|
|
Jan 07
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
16,369
-0.65%
|
$0
$0.95 P/Share
|
|
Jan 07
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,862
-0.39%
|
$0
$0.95 P/Share
|
|
Jan 03
2024
|
Chelsea Clinton Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+27.56%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Anna U Loengard Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+33.91%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Carladenise Armbrister Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+33.34%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
William G Robinson Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+31.06%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Lee Shapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+27.72%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Demetrios L. Kouzoukas Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+30.69%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
26,240
-1.04%
|
$0
$0.92 P/Share
|
|
Jan 01
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
1,559
-0.06%
|
$0
$0.95 P/Share
|
|
Jan 01
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084,906
-8.99%
|
$0
$0.95 P/Share
|
|
Dec 15
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,691
-0.34%
|
$0
$0.99 P/Share
|
|
Dec 15
2023
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,361
-0.43%
|
$0
$0.99 P/Share
|
|
Dec 14
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
12,567
-0.49%
|
$12,567
$1.0 P/Share
|
|
Dec 14
2023
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
96,086
-3.11%
|
$96,086
$1.0 P/Share
|
|
Nov 14
2023
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,079
-0.5%
|
$5,079
$1.01 P/Share
|
|
Nov 09
2023
|
Aric R Sharp CEO of Value Based Care |
SELL
Payment of exercise price or tax liability
|
Direct |
10,515
-0.58%
|
$0
$0.88 P/Share
|
|
Nov 08
2023
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
83,514
-0.69%
|
$0
$0.9 P/Share
|
|
Oct 31
2023
|
Karen Soares General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
600,000
+37.28%
|
-
|
|
Oct 31
2023
|
Clover Health Investments, Corp. /De Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
440,000
+12.45%
|
-
|
|
Oct 31
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
600,000
+19.04%
|
-
|
|
Oct 31
2023
|
Brady Patrick Priest CEO of Home Care |
BUY
Grant, award, or other acquisition
|
Direct |
440,000
+18.26%
|
-
|
|
Oct 31
2023
|
Scott J. Leffler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+7.49%
|
-
|
|
Oct 31
2023
|
Aric R Sharp CEO of Value Based Care |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+12.11%
|
-
|
|
Oct 25
2023
|
Scott J. Leffler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
124,002
-2.66%
|
$0
$0.91 P/Share
|
|
Oct 18
2023
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
32,416
-2.08%
|
$0
$0.99 P/Share
|
|
Sep 15
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
21,511
-1.09%
|
$21,511
$1.13 P/Share
|
|
Sep 14
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
7,776
-0.39%
|
$7,776
$1.13 P/Share
|
|
Sep 14
2023
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
96,086
-3.49%
|
$96,086
$1.13 P/Share
|
|
Sep 07
2023
|
Aric R Sharp CEO of Value Based Care |
SELL
Payment of exercise price or tax liability
|
Direct |
138,477
-8.13%
|
$138,477
$1.31 P/Share
|
|
Sep 07
2023
|
Aric R Sharp CEO of Value Based Care |
BUY
Grant, award, or other acquisition
|
Direct |
1,368,750
+44.57%
|
-
|
|
Sep 07
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
52,967
-2.6%
|
$52,967
$1.31 P/Share
|
|
Sep 07
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
652,452
+24.29%
|
-
|
|
Sep 06
2023
|
Anna U Loengard Director |
BUY
Open market or private purchase
|
Indirect |
11,000
+34.26%
|
$11,000
$1.3 P/Share
|
|
Aug 09
2023
|
Aric R Sharp CEO of Value Based Care |
SELL
Payment of exercise price or tax liability
|
Direct |
7,037
-2.05%
|
$7,037
$1.39 P/Share
|
|
Aug 08
2023
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
277,720
-2.23%
|
$277,720
$1.33 P/Share
|
|
Jul 25
2023
|
Scott J. Leffler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
387,173
-7.66%
|
$387,173
$1.09 P/Share
|
|
Jul 18
2023
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
133,438
-7.87%
|
$133,438
$1.06 P/Share
|
|
Jun 14
2023
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
86,763
-3.06%
|
$0
$0.94 P/Share
|
|
Jun 14
2023
|
Joseph Richards Martin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
98,827
-3.51%
|
$0
$0.94 P/Share
|
|
Jun 14
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
7,776
-0.56%
|
$0
$0.94 P/Share
|
|
May 15
2023
|
Demetrios L. Kouzoukas Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,585
+12.36%
|
-
|
|
May 09
2023
|
Aric R Sharp CEO of Value Based Care |
SELL
Payment of exercise price or tax liability
|
Direct |
28,148
-7.59%
|
$0
$0.93 P/Share
|